(UroToday.com) As a portion of the European Society for Medical Oncology (ESMO) Annual Congress, an Educational Session focused on personalized care in genitourinary cancers was held. In this context, Dr. Matthew Galsky presented the role of tissue and blood-based biomarkers for urothelial cancer.